🇺🇸 FDA

Company profile · Sponsor

CureVac

CureVac AG

E25BB09 · EMA pharma EU
Pipeline
1
Drugs
0
Patents
0

Quick answer

CureVac (E25BB09) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E25BB09
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (1)

Search pipeline →

  1. A trial to find out how well CVHNLC works at different dose levels and how safe it is in combination with pembrolizumab in patients with lung cancer that cannot be completely cured.

    CureVac

    metastatic squamous non-small cell lung cancer

    phase 1 other active

    1 trial

Frequently asked questions

What is CureVac?

CureVac (E25BB09) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does CureVac sponsor?

We track 1 ClinicalTrials.gov-linked program for CureVac, including A trial to find out how well CVHNLC works at different dose levels and how safe it is in combination with pembrolizumab in patients with lung cancer that cannot be completely cured.. Open each program for phase, modality, NCT IDs, and indication details.

Where does CureVac company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.